NCT04650178View on ClinicalTrials.gov

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Active, not recruitingOBSERVATIONAL
Enrollment

274

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmNeuropathy
Interventions
OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete questionnaire

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER